TRPA1 activation by isothiocyanates is followed by strong desensitisation [14,15,16]; self- and cross-desensitisation of TRPA1 and TRP subfamily vanilloid member 1 (TRPV1), seems to be relevant to the anti-migraine properties of some analgesics [17]. This evidence concerns the gene TRPA1 and migraine disorder.